A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy

Grace K. Dy, Dheerendra Prasad, Prasanna Kumar, Kristopher Attwood, Alex A. Adjei

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e19-e20
JournalJournal of Thoracic Oncology
Issue number3
StatePublished - Mar 2021

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this